BWAY News and Press, BrainsWay Ltd. From 01/21/20

CARY, N.C., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Greenbrook TMS NeuroHealth Centers , one of the leading providers of Transcranial Magnetic Stimulation (TMS) therapy in the United States, announced today that it is now offering BrainsWay’s Deep TMS therapy for patients with obses...

NEWPORT NEWS, Va., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Greenbrook TMS NeuroHealth Centers , one of the leading providers of mental health services in the United States, is now offering BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for patients with obsess...

Throughout the course of 2019, investors in the medical device space were interested in a variety of stories on the growth and catalysts available to companies in this sector. From US Food and Drug Administration (FDA) news to global expansion and updates on the development process for medic...

Gainers:  Kodiak Sciences (NASDAQ: KOD )  +70% . More news on: Kodiak Sciences Inc., ASLAN Pharmaceuticals Limited, Cortexyme, Inc., Stocks on the move, Read more ...

Primary and secondary endpoint achieved with statistical significance Company intends to meet with FDA shortly to discuss planned regulatory submission and potential clearance pathway JERUSALEM, Dec. 02, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“Bra...

Brainsway Ltd. (BWAY) Q3 2019 Earnings Conference Call November 25, 2019 9:00 a.m. ET Company Participants Brian Ritchie - LifeSci Advisors David Zacut - Chairman and Interim CEO Hadar Levy - COO and CFO Christopher von Jako - Incoming CEO and President Conference Call Parti...

JERUSALEM, Israel and HACKENSACK, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today reported financial results for the ...

JERUSALEM and HACKENSACK, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) and its subsidiary BrainsWay USA, Inc., a global leader in the advanced non-invasive treatment of brain disorders, today announced that its Board of Directors has decided to ...

JERUSALEM, Nov. 25, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ: BWAY, TASE: BWAY), a global leader in the advanced non-invasive treatment of brain disorders, announced today that it will be exhibiting its new state-of-the-art deep transcranial magnetic stimulation (dTMS) platform for t...

JERUSALEM and HACKENSACK, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that it will report its third qua...